Dose Augmented Rituximab and Ice for Patients With Primary Refractory and Poor Risk Relapsed Aggressive B-Cell Non-Hodgkin's Lymphoma

This study is ongoing, but not recruiting participants.

Study NCT00588094 Information provided by Memorial Sloan-Kettering Cancer Center

First Received: December 26, 2007 Last Updated: March 17, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	October 2010
Estimated Primary Completion Date:	October 2010 (Final data collection date for primary outcome measure)